Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Lower Genital Tract Disease|June 2, 2012
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introductionJulia W Gargano, Edward J Wilkinson, Elizabeth R Unger, et al.
International Journal of Cancer|July 29, 2022
HPV type-specific trends in cervical precancers in the United States, 2008 to 2016Julia W Gargano, Nancy McClung, Rayleen M Lewis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 2026
Decreases in human papillomavirus vaccine types 16 and 18 in cervical precancers - HPV-IMPACT, 2008-2019Ruth Stefanos, Julia W Gargano, Linda M Niccolai, et al.
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022Julia W Gargano, Ruth Stefanos, Rebecca M Dahl, et al.
MMWR. Morbidity and Mortality Weekly Report|May 20, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021Megan Wallace, Kate R Woodworth, Julia W Gargano, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.
Emerging Infectious Diseases|December 22, 2020
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United StatesSarah A Collier, Li Deng, Elizabeth A Adam, et al.
Pageof 5